TScan Therapeutics, Inc.

TCRX

—

Advanced chart & tools →

TScan Therapeutics, Inc.TCRX

$0.00

+$0.00(+NaN%)Past Year

Jun 25Sep 25Dec 25Mar 26Jun 26

Key statistics

Market cap

—

P/E ratio

—

EPS (diluted)

$-1.00

Dividend yield

0.00%

Dividend / share

$0.00

Revenue

$10.32M

Net income

$-129.77M

Net margin

-1256.8%

Gross margin

—

Dividends & financials

TScan Therapeutics, Inc. (TCRX) reported revenue of $10.32M and net income of $-129.77M, or $-1.00 per diluted share. It does not currently pay a dividend. Financial figures are sourced from the company’s latest public filings; the price chart updates live, 24/7, even when the underlying market is closed.